Recognizing Checkpoint Inhibitor Toxicities in Patients

The chapter emphasizes the importance of identifying and managing toxicities in patients on checkpoint inhibitors, stressing the critical role of healthcare providers in recognizing adverse events early. It discusses the increasing prevalence of patients on these medications and the need for vigilance in monitoring for potential side effects.